StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Intangible asset (IPR&D) impairment charges by Quarter

Intangible asset (IPR&D) impairment charges ($M) ($M)

QuarterlyAnnual

Vertex Pharmaceuticals Intangible asset (IPR&D) impairment charges: $0M in Q2 2026. That is the lowest of the 20 quarters on record here.

Latest, Q2 2026
0
Period ended Jun 30, 2026
Change on a year earlier
–
0 in Q2 2025
History
20 quarters
Since Q3 2016
Sources
9
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K Consolidated Statements of Operations.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIntangible asset (IPR&D) impairment charges ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20260–Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 31, 20260-100.0%Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 20250–Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 20250–Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 20250–Form 10-Q (filed 2026-08-04) ↗
Q1 2025Mar 31, 2025379–Form 10-Q (filed 2026-08-04) ↗
Q4 2024Dec 31, 20240–Form 10-K (filed 2026-02-13) ↗
Q3 2024Sep 30, 20240–Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 20240–Form 10-Q (filed 2025-08-05) ↗
Q1 2024Mar 31, 20240–Form 10-Q (filed 2025-05-06) ↗
Q4 2018Dec 31, 201829–Form 10-K (filed 2020-02-13) ↗
Q3 2018Sep 30, 20180-100.0%Form 10-K (filed 2020-02-13) ↗
Q2 2018Jun 30, 20180–Form 10-K (filed 2020-02-13) ↗
Q1 2018Mar 31, 20180–Form 10-K (filed 2020-02-13) ↗
Q4 2017Dec 31, 20170–Form 10-K (filed 2019-02-13) ↗
Q3 2017Sep 30, 2017255–Form 10-K (filed 2019-02-13) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Intangible asset (IPR&D) impairment charges ($M), quarterly Q3 2016–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/iprd-impairment

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.